NRx
-
NRx in Radnor Pens $345M+ Deal to Market Bipolar Drug
NRx Pharmaceuticals in Radnor has signed a licensing deal for its new drug candidate targeting bipolar depression, writes John George for Philadelphia Business Journal. The…
-
NRx in Radnor Now Seeks Patent for COVID Drug Zyesami, Sees Other Uses
NRx Pharmaceuticals has now added a patent application to its paperwork for the COVID-19 therapy drug Zyesami, writes John George for Philadelphia Business Journal. Earlier…
-
NRx in Radnor Cleared to Use Its COVID-19 Drug in Country of Georgia
With COVID-19 cases growing by 1,000 cases a day, the country of Georgia has issued an emergency authorization to use a COVID-19 therapy, Zyesami, developed…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
